Since cysteine is known to be neurotoxic in excessive amounts [32], treatment with N-acetylcysteine should not be recommended for patients with glutathione synthetase deficiency as this may increase the intracellular cysteine levels even more
Comparative analysis found GHK-Cu improved collagen production in 70% of treated women, compared to 50% with vitamin C cream and 40% with retinoic acid
The goal is matching risk tolerance to available options rather than seeking nonexistent perfect safety
Individual response and healthcare provider recommendations determine the precise timing between injections, allowing for personalized treatment protocols that optimize results while maintaining safety
For example, jaundice, characterized by yellowing of the skin and eyes, occurs when the liver is unable to process bilirubin effectively
IGF-1 treatment: future and limitations The FDA approved the use of rhIGF-1 (Mecasermin, Increlex) for treatment of severe primary IGF-1 deficiency in 2003